Tue, January 4, 2022
Mon, January 3, 2022
Sun, January 2, 2022
Fri, December 31, 2021
Thu, December 30, 2021
Wed, December 29, 2021
Tue, December 28, 2021
Mon, December 27, 2021
Thu, December 23, 2021
Wed, December 22, 2021
Tue, December 21, 2021
Mon, December 20, 2021
Fri, December 17, 2021
Thu, December 16, 2021

Patrick Trucchio Maintained (VIR) at Strong Buy with Increased Target to $300 on, Dec 21st, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-300-on-dec-21st-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Patrick Trucchio of HC Wainwright & Co., Maintained "Vir Biotechnology, Inc." (VIR) at Strong Buy with Increased Target from $200 to $300 on, Dec 21st, 2021.

Patrick has made no other calls on VIR in the last 4 months.



There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, all agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Anupam Rama of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $37 on, Monday, October 25th, 2021
  • Paul Choi of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $62 on, Wednesday, September 22nd, 2021

Publication Contributing Sources